ClearPoint Neuro (CLPT) Stock Chart & Stock Price History → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free CLPT Stock Alerts $5.43 -0.12 (-2.16%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ClearPoint Neuro Stock Price Performance5 Day Performance-1.45%1 Month Performance-1.63%3 Month Performance-18.71%6 Month Performance-8.74%Year-To-Date Performance-20.03%1 Year Performance-30.07% Receive CLPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. CLPT Stock Chart for Sunday, June, 2, 2024 CLPT Chart by TradingView ClearPoint Neuro Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$5.55$5.43-2.16%$5.67$5.16124,059 shs$148.89 million05/30/2024$5.55$5.55$5.62$5.30138,602 shs$152.18 million05/29/2024$5.51$5.55+0.73%$5.70$5.41130,154 shs$152.18 million05/28/2024$5.87$5.51-6.13%$5.85$5.14517,573 shs$151.08 million05/27/2024$5.87$5.87$6.26$5.80149,900 shs$160.96 million05/24/2024$6.21$5.87-5.48%$6.26$5.80149,911 shs$160.96 million Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$6.06$6.21+2.48%$6.25$5.92210,535 shs$170.28 million05/22/2024$6.07$6.06-0.16%$6.18$5.89182,475 shs$166.17 million05/21/2024$6.13$6.07-0.98%$6.17$5.8791,555 shs$166.44 million05/20/2024$6.20$6.13-1.13%$6.37$5.92156,246 shs$168.09 million05/17/2024$6.40$6.20-3.13%$6.42$6.0978,994 shs$170.00 million05/16/2024$6.40$6.40$6.51$6.38142,292 shs$175.49 million05/15/2024$6.01$6.40+6.49%$6.42$6.05190,975 shs$175.49 million05/14/2024$5.85$6.01+2.74%$6.02$5.89125,706 shs$164.79 million05/13/2024$5.86$5.85-0.17%$6.07$5.7680,636 shs$160.41 million05/10/2024$6.11$5.86-4.09%$6.16$5.65168,667 shs$158.63 million05/09/2024$5.99$6.11+2.00%$6.18$5.86188,779 shs$165.40 million05/08/2024$5.89$5.99+1.70%$6.52$5.85206,887 shs$162.15 million05/07/2024$5.94$5.89-0.84%$6.09$5.86138,175 shs$159.44 million05/06/2024$5.87$5.94+1.19%$6.04$5.8282,911 shs$160.80 million05/03/2024$5.52$5.87+6.34%$5.88$5.5974,501 shs$158.90 million05/02/2024$5.42$5.52+1.85%$5.55$5.3774,795 shs$149.43 million05/01/2024$5.43$5.42-0.18%$5.63$5.35125,129 shs$146.72 million04/30/2024$5.33$5.43+1.88%$5.50$5.2982,559 shs$146.99 million04/29/2024$5.26$5.33+1.33%$5.45$5.11153,474 shs$144.28 million04/26/2024$5.31$5.26-0.94%$5.43$5.13168,814 shs$142.39 million04/25/2024$5.32$5.31-0.19%$5.40$5.19151,450 shs$143.74 million04/24/2024$5.50$5.32-3.27%$5.52$5.2759,294 shs$144.01 million04/23/2024$5.51$5.50-0.18%$5.63$5.4355,240 shs$148.89 million04/22/2024$5.33$5.51+3.38%$5.57$5.3148,516 shs$149.16 million04/19/2024$5.39$5.33-1.11%$5.49$5.25129,079 shs$144.28 million04/18/2024$5.53$5.39-2.53%$5.69$5.3586,697 shs$145.91 million04/17/2024$5.58$5.53-0.90%$5.67$5.47137,165 shs$149.70 million04/16/2024$5.61$5.58-0.53%$5.77$5.52113,266 shs$151.05 million04/15/2024$5.81$5.61-3.44%$6.09$5.35304,735 shs$151.86 million04/12/2024$6.20$5.81-6.29%$6.23$5.72194,220 shs$157.28 million04/11/2024$6.16$6.20+0.65%$6.28$6.1058,081 shs$167.83 million04/10/2024$6.38$6.16-3.45%$6.32$6.02101,295 shs$166.75 million04/09/2024$6.28$6.38+1.59%$6.39$6.2274,200 shs$172.13 million04/08/2024$6.43$6.28-2.33%$6.53$6.19139,598 shs$169.43 millionThe Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.04/05/2024$6.38$6.43+0.78%$6.53$6.3257,354 shs$173.48 million04/04/2024$6.60$6.38-3.33%$6.71$6.3286,870 shs$172.13 million04/03/2024$6.45$6.60+2.33%$6.63$6.3765,358 shs$178.04 million04/02/2024$6.73$6.45-4.16%$6.57$6.3697,571 shs$174.02 million04/01/2024$6.80$6.73-1.03%$6.81$6.4878,236 shs$181.58 million03/29/2024$6.80$6.80$6.92$6.6684,050 shs$183.46 million03/28/2024$6.72$6.80+1.19%$6.92$6.6684,050 shs$183.44 million03/27/2024$6.54$6.72+2.75%$6.72$6.5483,797 shs$181.31 million03/26/2024$6.74$6.54-2.97%$6.77$6.50133,540 shs$176.45 million03/25/2024$6.57$6.74+2.59%$6.82$6.45167,043 shs$181.85 million03/22/2024$6.82$6.57-3.67%$6.85$6.5596,694 shs$177.26 million03/21/2024$7.00$6.82-2.57%$7.03$6.80111,921 shs$184.00 million03/20/2024$6.98$7.00+0.29%$7.06$6.71162,562 shs$188.86 million03/19/2024$7.07$6.98-1.27%$7.14$6.90137,590 shs$188.32 million03/18/2024$7.15$7.07-1.12%$7.21$6.93105,581 shs$190.75 million03/15/2024$7.21$7.15-0.83%$7.38$6.96353,427 shs$192.91 million03/14/2024$7.17$7.21+0.56%$7.26$7.00202,412 shs$177.86 million03/13/2024$6.05$7.17+18.51%$7.38$6.52710,515 shs$149.24 million03/12/2024$6.03$6.05+0.33%$6.09$5.95182,876 shs$149.25 million03/11/2024$6.19$6.03-2.58%$6.34$5.90157,091 shs$148.76 million03/08/2024$6.06$6.19+2.15%$6.28$6.09185,010 shs$152.71 million03/07/2024$6.24$6.06-2.81%$6.29$6.00226,914 shs$149.50 million03/06/2024$6.17$6.24+1.05%$6.68$6.23139,939 shs$153.82 million03/05/2024$6.50$6.17-5.08%$6.47$6.07347,113 shs$152.21 million03/04/2024$6.68$6.50-2.69%$6.77$6.22243,389 shs$160.34 million03/01/2024$6.39$6.68+4.54%$6.77$6.37311,391 shs$164.46 million Related Companies: Apyx Medical Stock Chart DarioHealth Stock Chart iCAD Stock Chart T2 Biosystems Stock Chart PolyPid Stock Chart Lyra Therapeutics Stock Chart SI-BONE Stock Chart Orthofix Medical Stock Chart Bioventus Stock Chart Iradimed Stock Chart Receive CLPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLPT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.